Coldstream Capital Management Inc. reduced its position in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 1.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,765 shares of the financial services provider’s stock after selling 693 shares during the period. Coldstream Capital Management Inc.’s holdings in Aflac were worth $5,606,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of the company. Forum Financial Management LP increased its stake in Aflac by 1.3% during the 2nd quarter. Forum Financial Management LP now owns 8,337 shares of the financial services provider’s stock worth $745,000 after buying an additional 107 shares in the last quarter. TriaGen Wealth Management LLC increased its stake in Aflac by 3.6% during the 2nd quarter. TriaGen Wealth Management LLC now owns 3,377 shares of the financial services provider’s stock worth $302,000 after buying an additional 117 shares in the last quarter. Graypoint LLC increased its stake in Aflac by 2.0% during the 2nd quarter. Graypoint LLC now owns 5,988 shares of the financial services provider’s stock worth $535,000 after buying an additional 118 shares in the last quarter. Jaffetilchin Investment Partners LLC increased its stake in Aflac by 1.7% during the 1st quarter. Jaffetilchin Investment Partners LLC now owns 7,254 shares of the financial services provider’s stock worth $623,000 after buying an additional 121 shares in the last quarter. Finally, Burns Matteson Capital Management LLC increased its stake in Aflac by 4.1% during the 2nd quarter. Burns Matteson Capital Management LLC now owns 3,077 shares of the financial services provider’s stock worth $275,000 after buying an additional 121 shares in the last quarter. 67.44% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Aflac
In other news, Director Thomas J. Kenny sold 2,000 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the sale, the director now owns 18,158 shares of the company’s stock, valued at $1,796,552.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.90% of the company’s stock.
Aflac Stock Up 0.5 %
Aflac (NYSE:AFL – Get Free Report) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.23. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The company had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $4.10 billion. During the same period in the prior year, the firm earned $1.58 earnings per share. The firm’s revenue was down .7% compared to the same quarter last year. Research analysts anticipate that Aflac Incorporated will post 6.75 EPS for the current year.
Aflac Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.83%. The ex-dividend date was Wednesday, August 21st. Aflac’s dividend payout ratio is currently 22.08%.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on the company. Bank of America upped their price target on Aflac from $108.00 to $115.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Truist Financial upped their price target on Aflac from $82.00 to $100.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. JPMorgan Chase & Co. upped their price target on Aflac from $80.00 to $83.00 and gave the company a “neutral” rating in a research report on Tuesday, July 2nd. Wells Fargo & Company upped their price target on Aflac from $81.00 to $90.00 and gave the company an “equal weight” rating in a research report on Monday, August 12th. Finally, Jefferies Financial Group dropped their price target on Aflac from $84.00 to $83.00 and set a “hold” rating for the company in a research report on Friday, June 28th. Three research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $92.50.
Get Our Latest Analysis on Aflac
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More
- Five stocks we like better than Aflac
- Insider Trades May Not Tell You What You Think
- Top Stress-Free Stock Picks to Secure Your Portfolio This Fall
- Best Stocks Under $10.00
- Amazon Stock is a Red Hot Bargain (For Now)
- What Investors Need to Know About Upcoming IPOs
- AI Disrupts SaaS: Salesforce, Workday Navigate Industry Shift
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.